Acute cholangitis (ascending cholangitis) is a clinical syndrome characterized by bacterial infection of the biliary tract in association with functional or mechanical obstruction of the common bile duct3,6. It represents a critical medical and surgical emergency that requires prompt recognition, aggressive fluid resuscitation, targeted antimicrobial therapy, and urgent biliary decompression to prevent fatal septic shock and multiorgan dysfunction syndrome3,5.

1. Etiology & Risk Factors

  • Choledocholithiasis: The most prevalent etiology, accounting for 30% to 50% of cases, where gallstones migrate from the gallbladder into the common bile duct, causing luminal occlusion and subsequent stasis5,7.
  • Benign Biliary Strictures: Post-surgical strictures (e.g., following cholecystectomy), chronic pancreatitis, primary sclerosing cholangitis (PSC), and anastomotic strictures after liver transplantation6.
  • Malignant Biliary Obstruction: Cholangiocarcinoma, pancreatic head adenocarcinoma, ampullary carcinoma, duodenal malignancies, and extrinsic compression from metastatic porta hepatis lymphadenopathy7.
  • Instrumental and Procedural Triggers: Iatrogenic inoculation or obstruction following endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), or biliary stenting with subsequent stent occlusion6.
  • Parasitic Infestations: Endemic infestations by liver flukes such as Clonorchis sinensis, Opisthorchis viverrini, or Ascaris lumbricoides invading the biliary tree6.
  • Predisposing Host Factors: Advanced age, immunosuppression, diabetes mellitus, indwelling biliary stents, and structural abnormalities of the papilla of Vater3,5.

2. Pathophysiology

The pathogenesis of acute cholangitis requires two fundamental conditions: elevated intraductal biliary pressure and bacterial contamination of the bile. Normally, bile is sterile, and sphincter of Oddi competence, continuous antegrade bile flow, and biliary secretory IgA prevent bacterial colonization. When mechanical or functional obstruction occurs, intraductal pressure rises rapidly. Once intraductal pressure exceeds 10 to 20 cm $H_2O$, tight junctions between hepatocytes are compromised, permitting biliary-venous and biliary-lymphatic reflux. This allows bacteria and their toxins to enter the systemic circulation, precipitating bacteremia and severe sepsis. Bacterial pathogens predominantly ascend from the duodenum, with common isolates including gram-negative bacilli such as Escherichia coli, Klebsiella species, Pseudomonas aeruginosa, and enterococci, alongside anaerobes like Bacteroides fragilis in polymicrobial infections5,7.

Acute cholangitis β€” Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Biliary tract obstruction induced by choledocholithiasis, benign stricture, or malignant neoplasm 2 Cellular / Pathophysiological Cascade Increased intraductal pressure coupled with ascending bacterial proliferation and translocation 3 Target Organ / Structural Change Hepatic parenchymal inflammation, microabscess formation, and biliary-venous reflux 4 Hallmark Clinical & Diagnostic Manifestation Charcot's triad (fever, jaundice, RUQ pain) progressing to Reynolds' pentad in severe sepsis 5 Complications if Untreated & Therapeutic Target Multiorgan dysfunction syndrome managed via urgent ERCP decompression and broad-spectrum antibiotics

3. Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients classically present with Charcot's triad: fever (often with shaking rigors), right upper quadrant (RUQ) abdominal pain, and jaundice. Fever is the most sensitive symptom (present in over 90% of cases), whereas jaundice reflects the underlying obstruction of bilirubin excretion. Severe or fulminant cases progress to Reynolds' pentad, which appends septic shock (hypotension) and central nervous system depression (confusion or altered mental status) to Charcot's triad3,7.
  • Physical Examination & Named Clinical Signs: Examination typically reveals marked RUQ tenderness and hepatomegaly. Murphy's sign may be positive if acute cholecystitis coexists, though it is characteristically less specific for isolated choledocholithiasis and cholangitis. Scleral icterus and generalized jaundice are universal in established biliary obstruction. Tachycardia, tachypnea, and hypotension indicate progression to systemic inflammatory response syndrome (SIRS) or septic shock.

4. Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationTokyo Guidelines 2018 diagnostic criteria combining systemic inflammation (fever, elevated WBC, elevated CRP) + cholestasis (jaundice, elevated ALP, GGT, conjugated bilirubin) + biliary dilatation or evidence of obstruction (choledocholithiasis, stricture, stent) on imaging1,4.
Laboratory PanelLeukocytosis with a left shift (elevated band forms), markedly elevated C-reactive protein (CRP), conjugated hyperbilirubinemia, elevated alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and moderate elevation of aminotransferases (AST/ALT). Severe cases show coagulopathy (elevated INR) and acute kidney injury (elevated BUN and creatinine)3,4.
Imaging / Radiology (X-ray, US, CT, MRI)Transabdominal ultrasound (US) is the initial screening modality revealing common bile duct dilation and intraluminal stones, though limited by bowel gas. Magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound (EUS) offer exceptional sensitivity for non-dilated ducts and small choledocholithiasis. Computed tomography (CT) scan provides superior evaluation for malignant obstructions and pancreatic pathology5,7.
ECG / Histopathology / ProceduralBlood cultures (positive in 40%–70% of cases) and bile cultures obtained during biliary decompression are mandatory to isolate causative pathogens and guide antibiotic de-escalation. Electrocardiogram (ECG) is performed to rule out cardiac ischemia given overlapping epigastric/RUQ pain presentations6,7.

5. Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Tokyo Guidelines 2018 Severity Grade I (Mild)Responsive to initial medical therapy and antibiotics alone; absence of organ dysfunction. Biliary drainage is indicated if medical therapy fails1,4.
Tokyo Guidelines 2018 Severity Grade II (Moderate)Associated with at least two of the following: abnormal leukocyte count ($>12,000$ or $<4,000/\mu L$), high fever ($>38.5^\circ C$), age $>75$ years, hyperbilirubinemia (total bilirubin $\ge 5\text{ mg/dL}$), or hypoalbuminemia. Requires early endoscopic biliary drainage1,4.
Tokyo Guidelines 2018 Severity Grade III (Severe)Onset of acute organ dysfunction involving at least one organ system (cardiovascular hypotension requiring vasopressors, neurological CNS depression/confusion, respiratory PaO2/FiO2 ratio $<300$, renal oliguria or creatinine $>2.0\text{ mg/dL}$, hepatic INR $>1.5$, or thrombocytopenia). Mandates urgent biliary decompression, intensive care unit (ICU) admission, and organ support1,4.

6. Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Acute CholecystitisInflammation of the gallbladder wall typically due to cystic duct obstruction by a gallstone. Features localized Murphy's sign, gallbladder wall thickening, and pericholecystic fluid, without common bile duct dilatation or marked conjugated hyperbilirubinemia unless Mirizzi syndrome or choledocholithiasis coexists1,2.
Acute PancreatitisSevere epigastric pain radiating to the back accompanied by serum lipase levels $>3$ times the upper limit of normal. Can coexist with acute gallstone pancreatitis if a gallstone impacts at the ampulla of Vater3,5.
Acute Hepatitis (Viral, Toxic, Ischemic)Marked transaminase elevation (often $>1000\text{ U/L}$) with disproportionately mild ALP elevation. Absence of biliary tree dilatation on imaging and negative markers for extrahepatic biliary obstruction6,7.
Liver AbscessFever, RUQ pain, and tender hepatomegaly. Imaging demonstrates well-defined fluid-filled hepatic parenchymal lesions rather than diffuse extrahepatic or intrahepatic biliary ductal dilatation6.

7. Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Immediate assessment of airway, breathing, and circulation (ABCs). Initiation of aggressive IV fluid resuscitation with crystalloids, correction of electrolyte disturbances and coagulopathies (using fresh frozen plasma or vitamin K as indicated), and close hemodynamic monitoring in a high-dependency or intensive care setting for moderate-to-severe cases1,3.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing): Prompt initiation of empiric IV broad-spectrum antimicrobial therapy covering enteric gram-negative bacilli, gram-positive organisms, and anaerobes. Recommended regimens include:
    • Piperacillin-tazobactam: $3.375\text{ g}$ to $4.5\text{ g}$ IV every 6 hours.
    • Alternative (Cephalosporin-based): Ceftriaxone $2\text{ g}$ IV every 24 hours PLUS Metronidazole $500\text{ mg}$ IV every 8 hours.
    • Alternative (Fluoroquinolone-based in non-severe community cases): Ciprofloxacin $400\text{ mg}$ IV every 12 hours PLUS Metronidazole $500\text{ mg}$ IV every 8 hours (adjusted for local antibiogram resistance profiles)2,6.
  • Surgical / Interventional Indications: Urgent biliary decompression is the cornerstone of therapy. Endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy and stone extraction, or biliary stenting, should be performed within 24 hours for Grade II/III disease and within 24–48 hours for Grade I disease. Alternative decompression modalities include percutaneous transhepatic cholangiography (PTC) when ERCP is anatomically unfeasible or fails, endoscopic ultrasound-guided biliary drainage (EUS-BD), or open/ laparoscopic surgical common bile duct exploration in refractory cases3,5,6.

8. Complications & Prognosis

  • Acute Complications: Septic shock, multiorgan dysfunction syndrome (MODS), acute respiratory distress syndrome (ARDS), acute kidney injury, hepatic microabscess formation, suppurative cholangitis, and biliary peritonitis secondary to ductal perforation3,6.
  • Prognosis & Mortality: Despite advances in endoscopic decompression and potent antimicrobial regimens, severe acute cholangitis carries an overall mortality rate ranging from 2% to 15%, which escalates significantly in elderly patients, delayed decompression scenarios, and cases complicated by multiorgan failure or underlying malignancy3,6.